Suhagra 25 mg Tablets - Sildenafil Citrate

Product Description

Suhagra 25 mg Tablet is a pharmaceutical product containing sildenafil, an active ingredient belonging to the phosphodiesterase type 5 (PDE5) inhibitor class. According to the supplied product information, each tablet contains sildenafil 25 mg, and the product is available in a pack of four tablets. The supplied listing identifies Cipla Ltd as the marketer. **Composition and Formulation** The stated composition is sildenafil 25 mg per tablet. The dosage form is a conventional oral tablet intended to be swallowed whole according to the prescribing instructions. Additional formulation details, including inactive ingredients, tablet dimensions, colour and storage requirements, are not specified in the provided information and should be confirmed using the product packaging or official prescribing information. **Therapeutic Use** Sildenafil is used to treat erectile dysfunction in eligible adult men. It works by inhibiting the PDE5 enzyme and supporting the nitric oxide–cyclic guanosine monophosphate pathway, which helps relax smooth muscle and increase blood flow in penile tissue during sexual stimulation. Sexual stimulation is required for the medicine to support an erection. The medicine does not independently cause sexual desire. Suhagra 25 mg should be used only under appropriate medical supervision. The correct dose and timing depend on individual health status, other medicines and the prescriber's instructions. Patients should not increase the dose or take additional erectile dysfunction medicines without consulting a healthcare professional. **Packaging and Product Identification** The supplied product listing describes a pack containing four tablets. The marketer is identified as Cipla Ltd, while the product is listed under the Suhagra brand. The source does not specify the manufacturing facility, country of origin, batch number, exact expiry date for the available stock or detailed packaging materials. These details should be checked against the physical pack and current product documentation before procurement. **Important Safety Information** Sildenafil can interact with nitrate medicines, including some medicines used for chest pain, and may cause a dangerous reduction in blood pressure. It may also interact with certain other medicines. People with cardiovascular conditions, low blood pressure, significant liver or kidney problems, or a recent history of serious cardiovascular events should obtain medical advice before use. Commonly reported adverse effects of sildenafil include headache, facial flushing, dizziness, indigestion and visual disturbances. Sudden loss of vision or hearing, chest pain or an erection lasting more than four hours requires urgent medical attention. Patients should avoid driving if they experience dizziness or visual disturbances and should discuss alcohol consumption with their healthcare professional. **Procurement and Verification** Pharmaceutical distributors and eligible buyers should verify the product name, sildenafil strength, four-tablet pack configuration, marketer details, batch number, expiry date and applicable regulatory documentation before procurement. The supplied information identifies Cipla Ltd as the marketer; this should not automatically be interpreted as independent verification of the manufacturer or of any specific batch. Product authenticity and authorization should be confirmed through reliable documentation before the listing is published or the product is supplied.

Additional Product Details

No additional product details available.

Product Specifications

Business Information